Search Results - "Rao, Shashidhar N"

Refine Results
  1. 1

    PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching by Dixon, Steven L., Smondyrev, Alexander M., Rao, Shashidhar N.

    Published in Chemical biology & drug design (01-05-2006)
    “…Pharmacophore modeling and 3D database searching are now recognized as integral components of lead discovery and lead optimization, and the continuing need for…”
    Get full text
    Journal Article
  2. 2

    Validation Studies of the Site-Directed Docking Program LibDock by Rao, Shashidhar N, Head, Martha S, Kulkarni, Amit, LaLonde, Judith M

    “…The performance of the site-features docking algorithm LibDock has been evaluated across eight GlaxoSmithKline targets as a follow-up to a broad validation…”
    Get full text
    Journal Article
  3. 3

    PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results by Dixon, Steven L, Smondyrev, Alexander M, Knoll, Eric H, Rao, Shashidhar N, Shaw, David E, Friesner, Richard A

    Published in Journal of computer-aided molecular design (01-10-2006)
    “…We introduce PHASE, a highly flexible system for common pharmacophore identification and assessment, 3D QSAR model development, and 3D database creation and…”
    Get full text
    Journal Article
  4. 4

    Experimental conformational energy maps of proteins and peptides by Balaji, Govardhan A., Nagendra, H. G., Balaji, Vitukudi N., Rao, Shashidhar N.

    “…ABSTRACT We have presented an extensive analysis of the peptide backbone dihedral angles in the PDB structures and computed experimental Ramachandran plots for…”
    Get full text
    Journal Article
  5. 5

    Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors by Rao, Shashidhar N.

    Published in Journal of molecular graphics & modelling (01-09-2017)
    “…[Display omitted] •Docked a series of 1,2,4-tri-substituted imidazolinone compounds into the ligand binding pockets of DFG-in and DFG-out p38 MAP Kinase and…”
    Get full text
    Journal Article
  6. 6

    Comprehending renin inhibitor’s binding affinity using structure-based approaches by Subramanian, Govindan, Rao, Shashidhar N.

    Published in Bioorganic & medicinal chemistry letters (15-12-2013)
    “…The performance of several structure-based design (SBD) approaches in predicting the binding affinity of diverse small molecule inhibitors co-crystallized to…”
    Get full text
    Journal Article
  7. 7

    An integrated computational workflow for efficient and quantitative modeling of renin inhibitors by Subramanian, Govindan, Rao, Shashidhar N.

    Published in Bioorganic & medicinal chemistry (15-01-2012)
    “…A new integrated computational workflow that couples the strength of the molecular overlay methods to achieve rapid and automated alignments along with 3D-QSAR…”
    Get full text
    Journal Article
  8. 8

    TRPV1 antagonism by piperazinyl-aryl compounds: A Topomer-CoMFA study and its use in virtual screening for identification of novel antagonists by Kristam, Rajendra, Rao, Shashidhar N., D’Cruz, Anne Sudha, Mahadevan, Vijayalakshmi, Viswanadhan, Vellarkad N.

    Published in Journal of molecular graphics & modelling (01-03-2017)
    “…[Display omitted] •Topomer-CoMFA and CoMFA based 3D-QSAR models developed for piperazinyl-aryl TRPV1 antagonists.•Virtual screening performed using one…”
    Get full text
    Journal Article
  9. 9

    Design, Synthesis, and Qualitative Structure–Activity Evaluations of Novel β-Secretase Inhibitors as Potential Alzheimer’s Drug Leads by Al-Tel, Taleb H, Semreen, Mohammad H, Al-Qawasmeh, Raed A, Schmidt, Marco F, El-Awadi, Raafat, Ardah, Mustafa, Zaarour, Rania, Rao, Shashidhar N, El-Agnaf, Omar

    Published in Journal of medicinal chemistry (22-12-2011)
    “…We have identified highly selective imidazopyridines armed with benzimidazol and/or arylimidazole as potent β-secretase inhibitors. The most effective and…”
    Get full text
    Journal Article
  10. 10

    Molecular docking studies in factor XIa binding site by Balaji, Govardhan A., Balaji, Vitukudi N., Rao, Shashidhar N.

    Published in Journal of molecular structure (15-03-2016)
    “…Factor XIa inhibitors have been identified to have potential as anticoagulants with robust efficacy and low bleeding risks. In light of their significance and…”
    Get full text
    Journal Article
  11. 11

    Docking and 3-D QSAR studies on the binding of tetrahydropyrimid-2-one HIV-1 protease inhibitors by Rao, Shashidhar N., Balaji, Govardhan A., Balaji, Vitukudi N.

    Published in Journal of molecular structure (24-06-2013)
    “…•Surflex-dock poses show greater observed propensity of hydrogen bonding with NH of Ile 150 compared to Glide poses.•The docking scores of Surflex-dock poses…”
    Get full text
    Journal Article
  12. 12

    Rational Design and Synthesis of Potent Dibenzazepine Motifs as β-Secretase Inhibitors by Al-Tel, Taleb H, Al-Qawasmeh, Raed A, Schmidt, Marco F, Al-Aboudi, Amal, Rao, Shashidhar N, Sabri, Salim S, Voelter, Wolfgang

    Published in Journal of medicinal chemistry (22-10-2009)
    “…We have identified small-molecule dibenzazepine inhibitors of β-secretase (BACE1). These BACE1 inhibitors possess two key salient features. The first is a…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Free energy perturbation calculations on binding and catalysis after mutating Asn 155 in subtilisin by Rao, Shashidhar N, Singh, U. Chandra, Bash, Paul A, Kollman, Peter A

    Published in Nature (London) (06-08-1987)
    “…Site-directed mutagenesis is a very powerful approach to altering the biological functions of proteins, the structural stability of proteins and the…”
    Get full text
    Journal Article
  15. 15

    Conformational Studies Using Molecular Mechanics on Model Peptides with 1-Aminocycloalkane 1-Carboxylic Acid Residues by Rao, Shashidhar N, Chan, Ming Fai, Balaji, Vitukudi N

    Published in Bulletin of the Chemical Society of Japan (01-02-1997)
    “…Peptides with conformationally restricted 1-aminocyclopropane-1-carboxylic acid (Acc3) moieties were previously shown to exhibit preference for γ-turn…”
    Get full text
    Journal Article
  16. 16

    Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods by EL YAZAL, Jamal, RAO, Shashidhar N, MEHL, Adrea, SLIKKER, William JR

    Published in Toxicological sciences (01-10-2001)
    “…Neurotoxic organophosphorous compounds are known to modulate their biological effects through the inhibition of a number of esterases including…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Partially Unified Multiple Property Recursive Partitioning (PUMP-RP) Analyses of Cyclooxygenase (COX) Inhibitors by Rao, Shashidhar N, Stockfisch, Thomas P

    “…We have carried out partially unified multiple property recursive partitioning (PUMP-RP) analyses on a database of cyclooxygenase (COX) inhibitors, using CART…”
    Get full text
    Journal Article
  19. 19
  20. 20

    N-Substituted dibenzoxazepines as analgesic PGE2 antagonists by Hallinan, E. Ann, Hagen, Timothy J, Husa, Robert K, Tsymbalov, Sofya, Rao, Shashidhar N, vanHoeck, Jean Pierre, Rafferty, Michael F, Stapelfeld, Awilda, Savage, Michael A, Reichman, Melvin

    Published in Journal of medicinal chemistry (01-10-1993)
    “…8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-acetylhydrazide (1, SC-19220) has been previously reported by us and others to be a PGE2…”
    Get full text
    Journal Article